ReviewPharmaceutical research2008

Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.

Carlos G Leon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.